{"id":17248,"date":"2021-11-30T08:59:26","date_gmt":"2021-11-30T07:59:26","guid":{"rendered":"http:\/\/mabdesign.fr\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/"},"modified":"2021-11-30T08:59:26","modified_gmt":"2021-11-30T07:59:26","slug":"gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/","title":{"rendered":"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies"},"content":{"rendered":"

Toulouse, France, October 17, 2021 \u2013 <\/strong>GTP Nano, a contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, announced the production of its first clinical batches at its Toulouse, France plant. A new entrant on the nanodrug market, GTP Nano is leveraging an original partnership with research organization CEA that includes ongoing support with nanoformulation and the development of the associated manufacturing processes, as well as with nanocharacterization.<\/p>\n

The nanovectorization of drugs, now used in certain precision therapies, has been the subject of pharmaceutical research and development for more than two decades. The technology has the capacity to transport drugs directly to where they are needed and gradually release the active ingredients, substantially increasing efficacy while reducing undesirable side effects. The global nanomedicine market is expected to be worth hundreds of billions of dollars by 2025, with the therapeutics segment forecasted to expand at an 8.3% compound annual growth rate (CAGR) over the next five years (sources: Market Data Forecast and Mordor Intelligence<\/em>).<\/p>\n

Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

GTP Nano & CEA validate an innovative manufacturing model for nanodrugs<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32],"tags":[],"class_list":["post-17248","post","type-post","status-publish","format-standard","hentry","category-news","category-our-members"],"yoast_head":"\nGTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies - MabDesign<\/title>\n<meta name=\"description\" content=\"GTP Nano & CEA validate an innovative manufacturing model for nanodrugs\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies - MabDesign\" \/>\n<meta property=\"og:description\" content=\"GTP Nano & CEA validate an innovative manufacturing model for nanodrugs\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-30T07:59:26+00:00\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies\",\"datePublished\":\"2021-11-30T07:59:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/\"},\"wordCount\":187,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/\",\"name\":\"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"datePublished\":\"2021-11-30T07:59:26+00:00\",\"description\":\"GTP Nano & CEA validate an innovative manufacturing model for nanodrugs\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies - MabDesign","description":"GTP Nano & CEA validate an innovative manufacturing model for nanodrugs","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/","og_locale":"en_US","og_type":"article","og_title":"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies - MabDesign","og_description":"GTP Nano & CEA validate an innovative manufacturing model for nanodrugs","og_url":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/","og_site_name":"MabDesign","article_published_time":"2021-11-30T07:59:26+00:00","author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies","datePublished":"2021-11-30T07:59:26+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/"},"wordCount":187,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/","url":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/","name":"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"datePublished":"2021-11-30T07:59:26+00:00","description":"GTP Nano & CEA validate an innovative manufacturing model for nanodrugs","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/gtp-nano-leverages-ceas-nanoup-rd-facility-to-validate-an-innovative-manufacturing-model-and-produce-its-first-batches-of-drugs-for-precision-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"GTP Nano leverages CEA\u2019s NanO\u2019up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision therapies"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=17248"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17248\/revisions"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=17248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=17248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=17248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}